About Monod
Monod is a company based in Seattle (United States) founded in 2021 by Alfredo Quijano Rubio and Daniel Silva Manzano.. Monod has raised $25 million across 2 funding rounds from investors including HHS, Matrix Capital and Pack Ventures. Monod offers products and services including NovoBody, LuxSit™ Pro, and NovoLISA. Monod operates in a competitive market with competitors including Cardea Bio, Hememics Biotechnologies, Nix, Aligned Bio and Olaris, among others.
- Headquarter Seattle, United States
- Founders Alfredo Quijano Rubio, Daniel Silva Manzano
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Monod Bio Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$25 M (USD)
in 2 rounds
-
Latest Funding Round
$290.07 K (USD), Grant
Jan 01, 2024
-
Investors
HHS
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Monod
Monod offers a comprehensive portfolio of products and services, including NovoBody, LuxSit™ Pro, and NovoLISA. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI-powered platform for computational protein engineering in research.
Advanced system for clinical diagnostics using protein design techniques.
Software for life sciences applications in protein analysis and innovation.
Unlock access to complete
Unlock access to complete
Funding Insights of Monod
Monod has successfully raised a total of $25M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $290.07 thousand completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $290,066
-
First Round
First Round
(15 Aug 2022)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Grant - Monod | Valuation |
investors |
|
| Aug, 2022 | Amount | Seed - Monod | Valuation | Matrix |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Monod
Monod has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Matrix Capital and Pack Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pack Ventures is involved in unspecified business activities.
|
Founded Year | Domain | Location | |
|
Investments in multiple sectors are made by Sahsen Ventures.
|
Founded Year | Domain | Location | |
|
Early investments in science-focused startups are made by BOOM Capital.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Monod
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Monod
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Monod Comparisons
Competitors of Monod
Monod operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardea Bio, Hememics Biotechnologies, Nix, Aligned Bio and Olaris, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital graphene biosensors are developed using machine learning.
|
|
| domain | founded_year | HQ Location |
Biopreservation platform for mammalian cells and biologics is developed.
|
|
| domain | founded_year | HQ Location |
Sweat-based biosensors are provided for body hydration monitoring.
|
|
| domain | founded_year | HQ Location |
Nanowire-based sensors and alignment technologies are provided for molecular detection.
|
|
| domain | founded_year | HQ Location |
In-vitro diagnostics are developed for oncology, transplants, and neurodegeneration.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Monod
Frequently Asked Questions about Monod
When was Monod founded?
Monod was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Where is Monod located?
Monod is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Who is the current CEO of Monod?
Daniel Silva Manzano is the current CEO of Monod. They have also founded this company.
Is Monod a funded company?
Monod is a funded company, having raised a total of $25M across 2 funding rounds to date. The company's 1st funding round was a Seed of $25M, raised on Aug 15, 2022.
What does Monod do?
Monod was founded in 2021 and is based in Seattle, United States. Biosensors are created by the company within the biotechnology sector to identify viral proteins, toxins, antibodies, and various other molecules. The platform relies on engineered proteins combined with de novo computational protein design. Detection capabilities extend to a broad spectrum of target molecules, supporting applications in health and diagnostics.
Who are the top competitors of Monod?
Monod's top competitors include Nix, Olaris and Aligned Bio.
What products or services does Monod offer?
Monod offers NovoBody, LuxSit™ Pro, and NovoLISA.
Who are Monod's investors?
Monod has 8 investors. Key investors include HHS, Matrix Capital, Pack Ventures, Sahsen Ventures, and BOOM Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.